Psychedelic trial therapists report emotional strain, role ambiguity, and weak institutional support in interviews about clinical research work

Psychedelic trial therapists face emotional strain, unclear professional boundaries, and uneven institutional support while working inside clinical research settings. Their accounts center on the tension between highly relational care and tightly controlled study protocols, where therapists must balance participant safety, scientific standardization, and their own ethical responsibilities. Interviews with therapists highlight practical pressures such as managing transference, handling intense participant experiences, and working within narrow role definitions that may not match what participants need. Training, supervision, and peer support emerge as critical but often insufficient safeguards for practitioners exposed to repeated high-intensity sessions. These dynamics matter because therapist wellbeing and role clarity can shape both participant care and trial quality. As psychedelic research expands, clinical systems need stronger support structures, clearer ethical frameworks, and more realistic recognition of the interpersonal labor built into psychedelic therapy studies.